Benjamin F. Edwards & Company’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-99
Closed -$3K 1719
2019
Q4
$3K Hold
99
﹤0.01% 1697
2019
Q3
$2K Hold
99
﹤0.01% 1728
2019
Q2
$3K Hold
99
﹤0.01% 1722
2019
Q1
$2K Hold
99
﹤0.01% 1597
2018
Q4
$2K Hold
99
﹤0.01% 1586
2018
Q3
$3K Hold
99
﹤0.01% 1466
2018
Q2
$2K Hold
99
﹤0.01% 1507
2018
Q1
$2K Hold
99
﹤0.01% 1508
2017
Q4
$2K Hold
99
﹤0.01% 1471
2017
Q3
$1K Hold
99
﹤0.01% 1487
2017
Q2
$2K Hold
99
﹤0.01% 1363
2017
Q1
$1K Hold
99
﹤0.01% 1304
2016
Q4
$1K Hold
99
﹤0.01% 1196
2016
Q3
$2K Sell
99
-6
-6% -$155 ﹤0.01% 1036
2016
Q2
$2K Hold
105
﹤0.01% 994
2016
Q1
$3K Hold
105
﹤0.01% 969
2015
Q4
$11K Buy
105
+54
+106% +$6.07K ﹤0.01% 812
2015
Q3
$9K Sell
51
-85
-63% -$19.8K ﹤0.01% 886
2015
Q2
$30K Buy
+136
New +$30.2K 0.01% 689
2015
Q1
Sell
-450
Closed -$64K 1125
2014
Q4
$64K Hold
450
0.01% 468
2014
Q3
$59K Hold
450
0.01% 481
2014
Q2
$57K Hold
450
0.01% 459
2014
Q1
$59K Hold
450
0.02% 434
2013
Q4
$53K Buy
+450
New +$49.3K 0.02% 427

Other funds holding BHC

Benjamin F. Edwards & Company's BHC Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of Bausch Health (BHC) in Q1 2020, closing a stake of 99 shares — an estimated $3K sold.

Benjamin F. Edwards & Company first reported a position in BHC in Q4 2013 and held it in 24 quarters. The position peaked at $64K in Q4 2014. 312 funds tracked by Wall St. Rank hold BHC as of Q1 2020.

  • Benjamin F. Edwards & Company reported no remaining Bausch Health position as of Q1 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 99 Bausch Health shares in Q1 2020, an estimated $3K.
  • Benjamin F. Edwards & Company first reported a position in Bausch Health in Q4 2013 and held it in 24 quarters.
  • Benjamin F. Edwards & Company's Bausch Health position peaked at $64K in Q4 2014.
  • 312 funds tracked by Wall St. Rank held Bausch Health as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.